NHS Framework Agreement for Branded Medicines – National
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £309,584,002 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 2 Jul 2021 |
| Procedure | open |
| OCID | ocds-h6vhtk-02b648 |
Awards (233)
This procurement was awarded to 147 suppliers. Values shown are per-award; the notice total is £309,584,002.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Abbvie Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Abbvie Ltd shared | £526,000,000 | 15 May 2022 | active |
| Accord-UK ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Accord-UK Ltd shared | £526,000,000 | 15 May 2022 | active |
| Accord-UK Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Accord-UK Ltd shared | · | · | active |
| Acre Pharma Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Aguettant Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Aguettant Ltd shared | £526,000,000 | 15 May 2022 | active |
| Alliance Pharmaceuticals Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Alliance Pharmaceuticals Limited shared | £526,000,000 | 15 May 2022 | active |
| ALMIRALL LIMITED shared | £1,351,341,890 | 30 Apr 2019 | active |
| AOP Orphan Ltd shared | £526,000,000 | 15 May 2022 | active |
| Aspen Pharmacare UK Limited shared | £526,000,000 | 15 May 2022 | active |
| Aspen Pharmacare UK Limited shared | £95,224,871 | 26 Sept 2021 | active |
| Aspen Pharmacare UK Limited shared | · | · | active |
| Aspen Pharma Ireland Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Aspire Pharma Limited shared | £526,000,000 | 15 May 2022 | active |
| Aspire Pharma Limited shared | £95,224,871 | 26 Sept 2021 | active |
| Aspire Pharma Limited shared | · | · | active |
| Aspire Pharma Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Astellas Pharma Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Astellas Pharma Ltd shared | · | · | active |
| AstraZeneca shared | £526,000,000 | 15 May 2022 | active |
| AstraZeneca UK LTD shared | £1,351,341,890 | 30 Apr 2019 | active |
| Aventis Pharma ltd t/a Sanofi shared | £526,000,000 | 15 May 2022 | active |
| Aventis Pharma ltd t/a Sanofi shared | £95,224,871 | 26 Sept 2021 | active |
| Aventis Pharma ltd t/a Sanofi shared | · | · | active |
| Aventis Pharma Ltd trading as Sanofi shared | £1,351,341,890 | 30 Apr 2019 | active |
| Baxter Healthcare Ltd shared | £526,000,000 | 15 May 2022 | active |
| Bayer Ltd shared | £526,000,000 | 15 May 2022 | active |
| Bayer Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Bayer Ltd shared | · | · | active |
| Bayer Plc shared | £1,351,341,890 | 30 Apr 2019 | active |
| B. Braun Medical Limited shared | £526,000,000 | 15 May 2022 | active |
| B. Braun Medical Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Beaver Visitec International Sales Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Biofrontera Pharma GmbH shared | £1,351,341,890 | 30 Apr 2019 | active |
| Biofrontera Pharma GmbH shared | £526,000,000 | 15 May 2022 | active |
| Biogen Idec UK Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Bristol-Myers Squibb Pharmaceuticals Ltd. shared | £1,351,341,890 | 30 Apr 2019 | active |
| Cambridge Healthcare Supplies Ltd shared | £526,000,000 | 15 May 2022 | active |
| CCMed Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Cenote Pharma Limited shared | £526,000,000 | 15 May 2022 | active |
| Chiesi Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Chiesi Limited shared | £526,000,000 | 15 May 2022 | active |
| Chiesi Limited shared | £95,224,871 | 26 Sept 2021 | active |
| Chiesi Limited shared | · | · | active |
| Cipla shared | £526,000,000 | 15 May 2022 | active |
| Cipla (EU) Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Clinigen Healthcare Limited shared | £526,000,000 | 15 May 2022 | active |
| Colonis Pharma Ltd shared | £526,000,000 | 15 May 2022 | active |
| Consilient Health shared | £1,351,341,890 | 30 Apr 2019 | active |
| Crescent Pharma Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Crescent Pharma Ltd shared | £526,000,000 | 15 May 2022 | active |
| CST Pharma Limited shared | £526,000,000 | 15 May 2022 | active |
| Day Lewis Medical Ltd shared | £526,000,000 | 15 May 2022 | active |
| Day Lewis Medical Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Day Lewis Medical Ltd shared | · | · | active |
| Desitin Pharma Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Dexcel Pharma Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Dexcel Pharma Ltd shared | £526,000,000 | 15 May 2022 | active |
| Dexcel Pharma Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Dexcel Pharma Ltd shared | · | · | active |
| Dr Falk Pharma UK Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Dr Falk Pharma UK Ltd shared | £526,000,000 | 15 May 2022 | active |
| Drugsrus Ltd shared | £526,000,000 | 15 May 2022 | active |
| DRUGSRUS LTD shared | £1,351,341,890 | 30 Apr 2019 | active |
| Eisai Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Eisai Ltd shared | £526,000,000 | 15 May 2022 | active |
| ELI LILLY & COMPANY LIMITED shared | £1,351,341,890 | 30 Apr 2019 | active |
| Eli Lilly & Company Ltd shared | £526,000,000 | 15 May 2022 | active |
| ennogen healthcare ltd shared | £526,000,000 | 15 May 2022 | active |
| Ennogen Healthcare Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| EVER Pharma UK Ltd. shared | £526,000,000 | 15 May 2022 | active |
| Ferndale Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Ferndale Pharmaceuticals Ltd shared | £526,000,000 | 15 May 2022 | active |
| Ferring Pharmaceutical shared | £1,351,341,890 | 30 Apr 2019 | active |
| Ferring Pharmaceuticals Ltd shared | £526,000,000 | 15 May 2022 | active |
| Ferring Pharmaceuticals Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Ferring Pharmaceuticals Ltd shared | · | · | active |
| Flynn Pharma Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| FLYNN PHARMA LTD shared | £526,000,000 | 15 May 2022 | active |
| FLYNN PHARMA LTD shared | £95,224,871 | 26 Sept 2021 | active |
| FLYNN PHARMA LTD shared | · | · | active |
| Focus Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Focus Pharmaceuticals Ltd shared | £526,000,000 | 15 May 2022 | active |
| Fontus Health Ltd shared | £526,000,000 | 15 May 2022 | active |
| Fresenius Kabi Limited shared | £526,000,000 | 15 May 2022 | active |
| Galen Limited shared | £526,000,000 | 15 May 2022 | active |
| Gedeon Richter (UK) Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Gedeon Richter UK Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Gedeon Richter UK Ltd shared | · | · | active |
| Generics [UK] ta Mylan shared | £1,351,341,890 | 30 Apr 2019 | active |
| Genzyme Therapeutics Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Gilead Sciences shared | £1,351,341,890 | 30 Apr 2019 | active |
| GlaxoSmithKline UK Limited shared | £526,000,000 | 15 May 2022 | active |
| GlaxoSmithKline UK Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Glenmark Pharmaceuticals Europe shared | £1,351,341,890 | 30 Apr 2019 | active |
| Glenmark Pharmaceuticals Europe Limited shared | £526,000,000 | 15 May 2022 | active |
| Glenmark Pharmaceuticals Europe Limited shared | £95,224,871 | 26 Sept 2021 | active |
| Glenmark Pharmaceuticals Europe Limited shared | · | · | active |
| Grunenthal shared | £526,000,000 | 15 May 2022 | active |
| Intrapharm Laboratories Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Intrapharm Laboratories Ltd shared | £526,000,000 | 15 May 2022 | active |
| Ipsen shared | £95,224,871 | 26 Sept 2021 | active |
| Ipsen shared | · | · | active |
| Ipsen Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Janssen-Cilag Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Janssen-Cilag Ltd shared | £526,000,000 | 15 May 2022 | active |
| Karo Pharma UK Ltd shared | £526,000,000 | 15 May 2022 | active |
| Kent Pharmaceuticals LTD shared | £1,351,341,890 | 30 Apr 2019 | active |
| Kent Pharma Ltd shared | £526,000,000 | 15 May 2022 | active |
| Kent Pharma Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Kent Pharma Ltd shared | · | · | active |
| Kyowa Kirin Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Kyowa Kirin Ltd shared | £526,000,000 | 15 May 2022 | active |
| LogixX Pharma Ltd shared | £526,000,000 | 15 May 2022 | active |
| Lupin Healthcare (UK) Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Lupin Healthcare (UK) Limited shared | £526,000,000 | 15 May 2022 | active |
| Macarthys Laboratories t/a Martindale Pharma shared | £1,351,341,890 | 30 Apr 2019 | active |
| Martindale Pharma shared | £526,000,000 | 15 May 2022 | active |
| Martindale Pharma shared | £95,224,871 | 26 Sept 2021 | active |
| Martindale Pharma shared | · | · | active |
| medac Pharma LLP shared | £1,351,341,890 | 30 Apr 2019 | active |
| medac Pharma LLP shared | £95,224,871 | 26 Sept 2021 | active |
| medac Pharma LLP shared | · | · | active |
| Merck shared | £1,351,341,890 | 30 Apr 2019 | active |
| Merck Serono Limited shared | £95,224,871 | 26 Sept 2021 | active |
| Merck Serono Limited shared | · | · | active |
| Merck Sharpe & Dohme (UK) Limited shared | £526,000,000 | 15 May 2022 | active |
| Mercury Pharmaceuticals Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Mercury Pharmaceuticals Limited shared | £526,000,000 | 15 May 2022 | active |
| mibe Pharma UK Ltd shared | £526,000,000 | 15 May 2022 | active |
| Morningside Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Morningside Pharmaeuticals shared | £526,000,000 | 15 May 2022 | active |
| Morningside Pharmaeuticals shared | £95,224,871 | 26 Sept 2021 | active |
| Morningside Pharmaeuticals shared | · | · | active |
| Mylan shared | £526,000,000 | 15 May 2022 | active |
| Mylan shared | £95,224,871 | 26 Sept 2021 | active |
| Mylan shared | · | · | active |
| Napp Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Napp Pharmaceuticals Ltd shared | £526,000,000 | 15 May 2022 | active |
| Napp Pharmaceuticals Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Napp Pharmaceuticals Ltd shared | · | · | active |
| Necessity Supplies Limited shared | £526,000,000 | 15 May 2022 | active |
| Neon Healthcare Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Neon Healthcare Ltd shared | £526,000,000 | 15 May 2022 | active |
| Nordic Pharma shared | £95,224,871 | 26 Sept 2021 | active |
| Nordic Pharma shared | · | · | active |
| Nordic Pharma Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Norgine Pharmaceuticals Limited shared | £526,000,000 | 15 May 2022 | active |
| Norgine Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Novartis Pharmaceuticals UK Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Novartis Pharmaceuticals UK Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Novartis Pharmaceuticals UK Ltd shared | · | · | active |
| Novo Nordisk shared | £526,000,000 | 15 May 2022 | active |
| Novo Nordisk Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Opella Healthcare UK LTD shared | £526,000,000 | 15 May 2022 | active |
| Oralieve UK Ltd shared | £526,000,000 | 15 May 2022 | active |
| Organon Pharmaceuticals UK Ltd shared | £526,000,000 | 15 May 2022 | active |
| Orifarm UK shared | £95,224,871 | 26 Sept 2021 | active |
| Orifarm UK shared | · | · | active |
| ORPHALAN UK LTD shared | £526,000,000 | 15 May 2022 | active |
| ParaPharm Development Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| PARI shared | £526,000,000 | 15 May 2022 | active |
| Pfizer Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Pfizer Ltd shared | £526,000,000 | 15 May 2022 | active |
| Pfizer Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Pfizer Ltd shared | · | · | active |
| Pharmacosmos UK Ltd shared | £526,000,000 | 15 May 2022 | active |
| Pharmacosmos UK Ltd. shared | £1,351,341,890 | 30 Apr 2019 | active |
| Pharmasure shared | £95,224,871 | 26 Sept 2021 | active |
| Pharmasure shared | · | · | active |
| QDEM PHARMACEUTICALS LIMITED shared | £95,224,871 | 26 Sept 2021 | active |
| QDEM PHARMACEUTICALS LIMITED shared | · | · | active |
| Ranbaxy UK shared | £526,000,000 | 15 May 2022 | active |
| Rayner Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Rayner Surgical Group Ltd shared | £526,000,000 | 15 May 2022 | active |
| RB UK Healthcare Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Reckitt Benckiser shared | £526,000,000 | 15 May 2022 | active |
| Recordati Rare Diseases UK Ltd shared | £526,000,000 | 15 May 2022 | active |
| Ridge Pharma shared | £95,224,871 | 26 Sept 2021 | active |
| Ridge Pharma shared | · | · | active |
| Roche Products Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Roche Products Ltd shared | £526,000,000 | 15 May 2022 | active |
| Roma Pharmaceuticals Limited shared | £526,000,000 | 15 May 2022 | active |
| Rosemont Pharmaceuticals Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Rosemont Pharmaceuticals Limited shared | £526,000,000 | 15 May 2022 | active |
| Sandoz Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Sandoz Ltd shared | £526,000,000 | 15 May 2022 | active |
| Sandoz Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Sandoz Ltd shared | · | · | active |
| SELECTIVE SUPPLIES LIMITED shared | £1,351,341,890 | 30 Apr 2019 | active |
| Selective Supplies Ltd. shared | £526,000,000 | 15 May 2022 | active |
| Stirling Anglian Pharmaceuticals Ltd shared | £526,000,000 | 15 May 2022 | active |
| Strides Pharma Uk LTD shared | £526,000,000 | 15 May 2022 | active |
| Takeda UK Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Takeda UK Ltd shared | £526,000,000 | 15 May 2022 | active |
| Takeda UK Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Takeda UK Ltd shared | · | · | active |
| Tetris Pharma Lts shared | £95,224,871 | 26 Sept 2021 | active |
| Tetris Pharma Lts shared | · | · | active |
| Teva UK Limited shared | £526,000,000 | 15 May 2022 | active |
| Teva UK Limited shared | £95,224,871 | 26 Sept 2021 | active |
| Teva UK Limited shared | · | · | active |
| TEVA UK LIMITED shared | £1,351,341,890 | 30 Apr 2019 | active |
| Thea Pharmaceuticals Limited shared | £526,000,000 | 15 May 2022 | active |
| Thea Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Theramex HQ UK shared | £95,224,871 | 26 Sept 2021 | active |
| Theramex HQ UK shared | · | · | active |
| Thornton and Ross Ltd shared | £526,000,000 | 15 May 2022 | active |
| TILLOMED LABORATORIES LIMITED shared | £1,351,341,890 | 30 Apr 2019 | active |
| Tillomed Laboratories ltd shared | £526,000,000 | 15 May 2022 | active |
| Tillomed Laboratories ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Tillomed Laboratories ltd shared | · | · | active |
| Tillotts Pharma UK Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Tillotts Pharma UK Ltd shared | £526,000,000 | 15 May 2022 | active |
| Torrent Pharma (UK) Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Torrent Pharma UK Ltd shared | £526,000,000 | 15 May 2022 | active |
| Typharm Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Typharm Ltd shared | £526,000,000 | 15 May 2022 | active |
| UCB Pharm Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| UL Global Pharma shared | £95,224,871 | 26 Sept 2021 | active |
| UL Global Pharma shared | · | · | active |
| Univar Solutions shared | £526,000,000 | 15 May 2022 | active |
| Wockhardt UK Limited shared | £526,000,000 | 15 May 2022 | active |
| Wockhardt UK Limited shared | £95,224,871 | 26 Sept 2021 | active |
| Wockhardt UK Limited shared | · | · | active |
| Zentiva Pharma UK Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Zentiva Pharma UK Ltd shared | £526,000,000 | 15 May 2022 | active |
| Zentiva Pharma UK Ltd shared | £95,224,871 | 26 Sept 2021 | active |
| Zentiva Pharma UK Ltd shared | · | · | active |
description
NHS Framework Agreement for Branded Medicines – National Annual Category Tender and National Tender
documents
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjsi/e3Cppj9sWEJrSQGy3rL_Vxypjh3iyzrVYibClJ6eN_M , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjsn/_8IvhfirV6V1vNKjD8TuS_L7D.VnVdTPwNfHktWqxAs , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjso/ShkYTvpfQznpIPDEfIFjhg66etISbC5oxtEPxMHUP1k , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjsp/zVtBAL4cCKRCglWlEfGc0RI6p9DNVDay59ELNMTP5wU , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjss/hhoO02vgrfibttNrZ.tIuBpkPzJAE5Ub_5LKUa.XMdM , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjst/cz78.EeuFP2MZmY5C4F3K0UN2kMFCzIb1quXLJJdC.o , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjsu/5XkmSNIJ1.BstAPznH9t853Z1umZNZWCR8nYQbtRvaw , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjsx/KuIIHtVBTlrRTDPAY6_QnbLNAP5G_i1O37vsUXvxXbE , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjsy/_U.79v8LYDdnkXsCaBIqazVEXXtfaM8i.b.0KmYH_gg , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjsz/CmmbLpvliPIH12k2lG0BD6LUeaK39rzGcbqZvRV610g , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjtC/pR9uuYeZ2rTRxSpymW1ALD9pxCf18gIEkp0584L2Jlo , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjtH/K6V9elF2JSErb76fij9aLlKEwGDBCNCGBx_5KtF2Gy8 , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjtM/Q8fJ2Btqg_m1NFt3XYeILIsynjTGjc2Bwa9Su5Y3ywk , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kk6f/fIDPkqTVCc1OMhSdYQ1AhAQyzJWXXlpoubW6ASs1wJg , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kk6k/53IjDNCcYTJBRlMnBpKCIJprTpN5GvZZjI8XBRDUVWA , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kkFI/ytymZSvFtqCFa3TznxAeoKQkLl06ajuAXB5aqa0lQUs , Link
- https://nhsengland.bravosolution.co.uk , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/43feb948-f0cb-455e-aed0-89b00e20e2a9 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/67c3adb8-8e54-497c-8e30-1ebb107d4d85 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/a1adf1af-3e0e-4d41-af1f-8c4bba7b3c8a , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/037bfc3c-6794-4098-b289-12789e502985 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/2cb2a084-3613-44cf-9c26-c36466223da3 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/570b0e43-9744-4e97-977b-3b3032aa7449 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/7fd2f8f3-59a9-4046-80fa-7f291545f3b2 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/8eea26ec-d94e-4418-8a36-62456618cb26 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/af313fee-a604-46e3-a6ee-7524e9e9cb1c , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/af651003-04b3-43f1-8005-cab7e29fde6c , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/bc26550b-3940-4766-a449-8ab3e22b50d3 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/c4afd279-50b5-4502-a181-0711b947be28 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/ccf7efb6-1f8f-4237-85bc-71d280783200 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/d0d5c13c-f19f-4886-92f7-f0583a7d0506 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/d699efd2-36fc-49c5-aa37-f4f8adf85d49 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/dea9f737-ed9b-4741-b375-8a49e2643646 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/ea26850f-aeac-491b-b541-5fb984137ab0 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
7 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 13 Dec 2018 | Tender (tender) | · | 67c3adb8-8e54-497c-8e30-1ebb107d4d85-258849 |
| 9 Aug 2019 | Award update (awardUpdate) | · | 166b70b9-418c-40ef-9712-5c4939822674-306787 |
| 28 May 2021 | Contract notice (F02) | Earlier regulations | 011990-2021 |
| 28 May 2021 | Tender (tender) | · | a1adf1af-3e0e-4d41-af1f-8c4bba7b3c8a-440180 |
| 19 Oct 2021 | Award (award) | · | ad668311-0540-4e17-b81f-0920d2db574d-477889 |
| 27 Oct 2021 | Contract award notice (F03) | Earlier regulations | 026946-2021 |
| 27 Apr 2023 | Award (award) | · | 0e2151e3-7662-46b2-9479-c5fa4025b150-640244 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.